Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses the use of follicular unit extraction for hair restoration using body hair, reporting no new clinical findings, and highlights its potential for advanced baldness cases with limited scalp donor hair.

This study found that the spermidine analog N1-methylspermidine prolonged hair follicle growth and decreased inflammation and oxidative stress in cultured hair follicles, suggesting potential relevance for treating inflammatory scalp diseases.

This study found that using autologous micrografts from scalp tissues significantly improved hair thickness and density in patients experiencing telogen effluvium following COVID-19, with notable improvements observed over a 6-month follow-up period.

This narrative review discusses the use of micrografts and minigrafts for facial and scalp reconstruction following various causes of hair loss and reports a high level of patient satisfaction with these techniques.

This study suggests that topical corticosteroids, potentially combined with oral zinc and followed by topical calcineurin inhibitors, may be effective for managing erosive pustular dermatosis of the scalp.

This article reviews recent advancements in understanding hair follicle biology, with a focus on the potential for gene therapy in treating alopecia, but it reports no new research findings.

This study demonstrated that human dermal mesenchymal stem cells can be differentiated into cardiomyocytes using 5-azacytidine, suggesting potential future applications for treating myocardial infarction.

This article discusses advancements in hair restoration techniques over 25 years, emphasizing a shift towards natural, undetectable results with the use of small grafts and reevaluated design philosophies, but reports no new clinical results.

In this study, patients with mild to moderate scalp seborrheic dermatitis experienced greater improvements in severity scores and quality of life with Lulican™ shampoo compared to Ketoconazole over four weeks, with similar safety profiles but better tolerability and cosmetic acceptability for LulicanTM.

This source reports that the approval of baricitinib and ritlecitinib, which are JAK inhibitors, has marked a significant advancement in treating severe alopecia areata (AA), and suggests that additional treatments with new mechanisms may further improve patient outcomes in the future.

In this case report, the researchers described two women with Crohn disease who developed alopecia related to TNF inhibitor therapy, noting various histopathological features of drug-induced alopecia and treating it effectively with different therapeutic approaches.

In this cadaveric study, lipofilling was found easier to perform on the face than the scalp, whereas nanofat grafting was particularly suited for precise injections in scalp areas, suggesting a combination of techniques could aid in treating alopecia.

This article discusses extensive scalp lifting for male-pattern alopecia and emphasizes the need for precise surgical techniques and understanding to minimize complications, but reports no new clinical results.

In this case report, the authors found that hair transplantation on a free microvascular flap may be a viable and effective option for achieving good aesthetic outcomes when treating residual alopecia following reconstruction of large scalp defects.

This case report describes a patient with Birt-Hogg-Dube syndrome exhibiting multiple fibrofolliculomas, acrochordons, and renal oncocytoma.

In this randomized controlled study, the researchers found that an herbal extract combination showed similar efficacy to 3% minoxidil solution in treating androgenetic alopecia over 24 weeks, with no significant safety concerns, suggesting it might be a viable alternative treatment.

In this study, tofacitinib treatment led to significant hair regrowth in 60% of patients with moderate-to-severe alopecia areata, suggesting potential for JAK inhibitors in treating this condition.

This study found that in dogs with post-clipping alopecia, microneedling with platelet-rich plasma may induce more rapid hair regrowth compared to microneedling alone, though results were similar by six months.

This study found that continuous itraconazole therapy was more effective than pulse therapy for treating tinea capitis caused by Microsporum ferrugineum, with a higher cumulative cure rate and no significant adverse effects.

In this study, injecting two different concentrations of botulinum toxin A was found to be safe and effective for treating androgenetic alopecia in Egyptian men and women, with improvements in hair grade and vellus hair density observed over six months.

This review assessed dermo-cosmetic treatments using prebiotics, probiotics, synbiotics, and other biotics for acne and scalp disorders, finding potential benefits, especially with multi-strain or synbiotic formulations, although challenges like formulation stability and the need for larger trials persist.

This study consolidates information on the unique structural and functional biology of Indian hair, reporting distinct scalp microbial ecology and trichoscopic parameters, which are important for diagnosing and treating hair conditions in Indian populations.

In this study, a polyherbal antifungal shampoo using plant-based ingredients such as Neem and Amla was formulated and showed significant antifungal activity, suggesting it could be a safe and effective natural alternative to synthetic shampoos for treating dandruff and scalp infections.

This article outlines a randomized trial to evaluate whether preoperative botulinum toxin administration can improve hair transplantation outcomes by reducing ischemia-induced graft failure.

This study explores the hypothesis that preoperative administration of botulinum toxin could enhance hair transplantation outcomes by improving scalp microenvironment and reducing ischemia-induced graft failure, using a randomized split-scalp controlled trial design.

This source reviews recent data on topical minoxidil, evaluating its pharmacology, mechanism of action, clinical effectiveness, and side effects in treating hair loss, although its precise mode of action remains unclear.

In this case report, a 19-year-old male with alopecia areata showed complete relief from symptoms and increased hair density after 90 days of Shamana therapy, suggesting its potential effectiveness in treating this condition with minimal side effects.

In this randomized trial, oral supplementation with Serenoa repens, pumpkin seed extracts, and cysteine significantly improved the clinical effectiveness of topical 5% minoxidil lotion for treating androgenic alopecia in men and women compared to minoxidil alone, with both treatments being well tolerated.

This study found that in individuals with alopecia, scalp microbial diversity decreased while Cutibacterium acnes abundance increased, and that treating Cutibacterium acnes-infected mice with Lactobacillus plantarum L30 improved hair follicle health and hair growth, suggesting a potential new treatment pathway for alopecia.

This review reports that alterations in the scalp, hair follicle, and gut microbiome are associated with alopecia, and interventions targeting microbiome dysbiosis may have potential in treating hair loss.